Press release
COVID-19 Competitive landscape Report 2022 by DelveInsight
COVID-19 pipeline constitutes 420+ key companies continuously working towards
developing 520+ COVID-19 treatment therapies, analyzes DelveInsight
COVID-19 is the result of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first isolated and identified in patients who were exposed at a seafood market in Wuhan City, Hubei Province, China in December 2019. Similar to findings related to SARS-CoV and Middle East respiratory syndrome coronavirus, SARS-CoV-2 is believed to cross species to initiate primary human infections; it is now spread primarily by human-to-human transmission.
DelveInsights, "COVID-19 - Competitive landscape, 2022," report provides comprehensive insights about 420+ companies and COVID-19 drugs in COVID-19 inhibitors Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
To know more about the COVID-19 Competitive landscape report, click here: https://www.delveinsight.com/report-store/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the COVID-19 Competitive landscape report:
• Leading COVID-19 Companies working in the market are Westvac Biopharma, Xenothera, Windtree Therapeutics, Vir Biotechnology, ViiV Healthcare, Verastem, VBL Therapeutics, Valneva, Trustem, Toscana Life Sciences, Throne Biotechnologies, Thirty respiratory Limited, Theravance Biopharma, TC BioPharm, Syntax for Science,S.L, SyneuRx, Swedish Orphan Biovitrum, Swedish Herbal Institute AB, Stemedica Cell Technologies, Sound Pharmaceuticals, Sorrento Therapeutics and Others.
• Key COVID-19 therapies in various stages of development include SKYCovione, Sotrovimab, Sargramostim, Tradipitant, XAV-19, MAD0004J08, RESP301, Niclosamide, Sinapultide, MAS-825, Maraviroc, Abivertinib, Ebselen, Duvelisib, TCB008 and Others.
• In April 2022, Direct Biologics, announced that the US Food and Drug Administration has awarded their EV drug product ExoFlo with a regenerative Medicine Advanced Therapy designation for the treatment of Acute Respiratory Distress Syndrome associated with COVID-19.
DelveInsight's COVID-19 Report covers around 520+ products under different phases of clinical development like
• Assessment by COVID-19 Product Type
• Assessment by Stage and Product Type of COVID-19
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration of COVID-19
• Assessment by COVID-19 Molecule Type
• Assessment by Stage and Molecule Type of COVID-19
Emerging COVID-19 Drugs Under Different Phases of Clinical Development Include:
Some of the COVID-19 therapies are Sotrovimab, SKYCovione and Many Others.
Further COVID-19 product details are provided in the report. Download the COVID-19 Pipeline report to learn more about the emerging COVID-19 therapies at: https://www.delveinsight.com/sample-request/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key companies in the COVID-19 Therapeutics Market:
Some of the COVID-19 Companies working in the market are Westvac Biopharma, Xenothera, Windtree Therapeutics, Vir Biotechnology, ViiV Healthcare, Verastem, VBL Therapeutics, Valneva, Trustem, Toscana Life Sciences, Throne Biotechnologies, Thirty respiratory Limited, Theravance Biopharma, TC BioPharm, Syntax for Science,S.L, SyneuRx, Swedish Orphan Biovitrum, Swedish Herbal Institute AB, Stemedica Cell Technologies, Sound Pharmaceuticals, Sorrento Therapeutics and Others.
Request for Sample PDF Report to know in detail about the recent developments and
advancements in COVID-19 clinical trials- https://www.delveinsight.com/sample-request/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content (TOC)
1. COVID-19 Pipeline Report Introduction
2. COVID-19 Pipeline Report Executive Summary
3. COVID-19 Pipeline: Overview
4. Analytical Perspective In-depth Commercial Assessment
5. COVID-19 Clinical Trial Therapeutics
6. COVID-19 Pipeline: Late Stage Products (Pre-registration)
7. COVID-19 Pipeline: Late Stage Products (Phase III)
8. COVID-19 Pipeline: Mid Stage Products (Phase II)
9. COVID-19 Pipeline: Early Stage Products (Phase I)
10. COVID-19 Pipeline Therapeutic Assessment
11. Inactive Products in the COVID-19 Pipeline
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Key COVID-19 Companies
14. Key Products in the COVID-19 Pipeline
15. Unmet Needs
16. COVID-19 Market Drivers and Barriers
17. Future Perspectives and Conclusion
18. Analyst Views
19. Appendix
Download Sample PDF Report to know more about @ https://www.delveinsight.com/sample-request/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
developing 520+ COVID-19 treatment therapies, analyzes DelveInsight
COVID-19 is the result of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first isolated and identified in patients who were exposed at a seafood market in Wuhan City, Hubei Province, China in December 2019. Similar to findings related to SARS-CoV and Middle East respiratory syndrome coronavirus, SARS-CoV-2 is believed to cross species to initiate primary human infections; it is now spread primarily by human-to-human transmission.
DelveInsights, "COVID-19 - Competitive landscape, 2022," report provides comprehensive insights about 420+ companies and COVID-19 drugs in COVID-19 inhibitors Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
To know more about the COVID-19 Competitive landscape report, click here: https://www.delveinsight.com/report-store/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the COVID-19 Competitive landscape report:
• Leading COVID-19 Companies working in the market are Westvac Biopharma, Xenothera, Windtree Therapeutics, Vir Biotechnology, ViiV Healthcare, Verastem, VBL Therapeutics, Valneva, Trustem, Toscana Life Sciences, Throne Biotechnologies, Thirty respiratory Limited, Theravance Biopharma, TC BioPharm, Syntax for Science,S.L, SyneuRx, Swedish Orphan Biovitrum, Swedish Herbal Institute AB, Stemedica Cell Technologies, Sound Pharmaceuticals, Sorrento Therapeutics and Others.
• Key COVID-19 therapies in various stages of development include SKYCovione, Sotrovimab, Sargramostim, Tradipitant, XAV-19, MAD0004J08, RESP301, Niclosamide, Sinapultide, MAS-825, Maraviroc, Abivertinib, Ebselen, Duvelisib, TCB008 and Others.
• In April 2022, Direct Biologics, announced that the US Food and Drug Administration has awarded their EV drug product ExoFlo with a regenerative Medicine Advanced Therapy designation for the treatment of Acute Respiratory Distress Syndrome associated with COVID-19.
DelveInsight's COVID-19 Report covers around 520+ products under different phases of clinical development like
• Assessment by COVID-19 Product Type
• Assessment by Stage and Product Type of COVID-19
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration of COVID-19
• Assessment by COVID-19 Molecule Type
• Assessment by Stage and Molecule Type of COVID-19
Emerging COVID-19 Drugs Under Different Phases of Clinical Development Include:
Some of the COVID-19 therapies are Sotrovimab, SKYCovione and Many Others.
Further COVID-19 product details are provided in the report. Download the COVID-19 Pipeline report to learn more about the emerging COVID-19 therapies at: https://www.delveinsight.com/sample-request/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key companies in the COVID-19 Therapeutics Market:
Some of the COVID-19 Companies working in the market are Westvac Biopharma, Xenothera, Windtree Therapeutics, Vir Biotechnology, ViiV Healthcare, Verastem, VBL Therapeutics, Valneva, Trustem, Toscana Life Sciences, Throne Biotechnologies, Thirty respiratory Limited, Theravance Biopharma, TC BioPharm, Syntax for Science,S.L, SyneuRx, Swedish Orphan Biovitrum, Swedish Herbal Institute AB, Stemedica Cell Technologies, Sound Pharmaceuticals, Sorrento Therapeutics and Others.
Request for Sample PDF Report to know in detail about the recent developments and
advancements in COVID-19 clinical trials- https://www.delveinsight.com/sample-request/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content (TOC)
1. COVID-19 Pipeline Report Introduction
2. COVID-19 Pipeline Report Executive Summary
3. COVID-19 Pipeline: Overview
4. Analytical Perspective In-depth Commercial Assessment
5. COVID-19 Clinical Trial Therapeutics
6. COVID-19 Pipeline: Late Stage Products (Pre-registration)
7. COVID-19 Pipeline: Late Stage Products (Phase III)
8. COVID-19 Pipeline: Mid Stage Products (Phase II)
9. COVID-19 Pipeline: Early Stage Products (Phase I)
10. COVID-19 Pipeline Therapeutic Assessment
11. Inactive Products in the COVID-19 Pipeline
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Key COVID-19 Companies
14. Key Products in the COVID-19 Pipeline
15. Unmet Needs
16. COVID-19 Market Drivers and Barriers
17. Future Perspectives and Conclusion
18. Analyst Views
19. Appendix
Download Sample PDF Report to know more about @ https://www.delveinsight.com/sample-request/covid-19-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
